Lyell Immunopharma (LYEL) Net Margin Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3,082.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,120.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -653.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,849.00 |
| 10 | Lyell Immunopharma | 373.31 Mn | 373.31 Mn | - | -133.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -133.90 Mn |
| Dec 31, 2025 | -29.89 Mn |
| Sep 30, 2025 | -9.56 Mn |
| Jun 30, 2025 | -20.09 Mn |
| Mar 31, 2025 | 86.08 Mn |
| Dec 31, 2024 | -138.06 Mn |
| Sep 30, 2024 | 7.87 Mn |
| Jun 30, 2024 | -12.28 Mn |
| Mar 31, 2024 | -153.59 Mn |
| Dec 31, 2023 | -40.32 Mn |
| Sep 30, 2023 | 192.98 Mn |
| Jun 30, 2023 | -22.45 Mn |
| Mar 31, 2023 | -7.70 Mn |
| Dec 31, 2022 | 164,969.00 |
| Sep 30, 2022 | -213.78 Mn |
| Jun 30, 2022 | 227,623.00 |
| Mar 31, 2022 | -1.01 Mn |
| Dec 31, 2021 | 955.00 |
| Sep 30, 2021 | 156,621.00 |
| Jun 30, 2021 | 85,134.00 |